ROAD TO RECOVERY
- A PROSPECTIVE 10 YEAR AUDIT OF A SINGLE IRISH CENTRE'S EXPERIENCE OF RETRO-PERITONEAL LYMPH NODE DISSECTION FOR METASTATIC TESTIS CANCER. Casey, R. C.; Aktar, M.; Hegarty, P.; Butler, M.; Thornhill, J. A. // Surgeon (Edinburgh University Press);Oct2008, Vol. 6 Issue 5, p294
Background: Retro-peritoneal lymph node dissection (RPLND) following chemotherapy is critical in advanced germ cell tumours with residual retro-peritoneal masses. Post-chemotherapy RPLND is more extensive, may require adjacent organ resection and has higher morbidity. The study aim was to...
- Testes cancer. Richie, Jerome P.; Einhorn, Lawrence H.; Foster, Richard S.; Jewett, Michael A. S.; Studer, Urs E. // Contemporary Urology;Jun2001, Vol. 13 Issue 6, p12
Part II. Provides information on the symposium of medical experts that focuses on the examination of a variety of modalities available to treat testis cancer. Discussion on the controversies about how to best manage the disease; Basis of the views on primary chemotherapy; Alleged toxicity...
- Outpatient drug therapy gaining for testicular cancers. Carrell, Steve // Drug Topics;3/4/96, Vol. 140 Issue 5, p72
Highlights the advantages of outpatient drug therapy for testicular cancers, from the 1996 genitourinary oncology conference held in Houston, Texas. Benefits of less toxic chemotherapies in the treatment of testicular cancers; Chemotherapy as an option for Stage 1 nonseminomatous germ cell...
- It Takes Balls. Webster, Donovan // Men's Health;Dec2002, Vol. 17 Issue 10, p128
Presents information on testicular cancer. Symptoms; Information on the surgical removal of the testicle to identify the type of the testicular cancer of the patient; Types of testicular cancer; Variations of chemotherapy.
- Mortality in patients with testicular cancer: report of the Anglia and Trent testicular tumour groups. Ellis, Matthew; Sikora, Karol // British Medical Journal (Clinical Research Edition);3/8/1986, Vol. 292 Issue 6521, p672
Investigates the prognosis of patients with testicular cancer. Evaluation of mortality rate; Importance of oncologists for the management of cancer; Use of chemotherapy for the treatment of cancer.
- Clean Gear May Contribute to Longer Life-For You & Your Gear. JORGENSEN, HALEY // Fire Chief;Jun2013, Vol. 57 Issue 6, p14
The article discusses the health hazards of fire fighters as they more often get exposed to hazardous chemicals and soot. It mentions a study conducted by the University of Cincinnati in Cincinnati, Ohio which found that fire fighters are twice more likely to develop testicular cancer and...
- 125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer. Christensen, T B; Engbaek, F; Marqversen, J; Nielsen, S I; Kamby, C; Maase, H von der // British Journal of Cancer;7/15/99, Vol. 80 Issue 10, p1577
The rate of reduction in the concentration of serum human chorionic gonadotrophin (hCG) following chemotherapy for germ cell tumours may follow a complex pattern, with longer apparent half-life during later stages of chemotherapy, even in patients treated successfully. The commonly used...
- Testicular relapse after chemotherapy for malignant teratoma. Chan, Stephen; Sikora, Karol // British Medical Journal (Clinical Research Edition);10/31/1987, Vol. 295 Issue 6606, p1098
Reports a case of a patient with extragonadal metastatic teratoma and testicular relapse after chemotherapy. Clinical manifestations of the disease; Administration of laparotomy; Evaluation on the pain experienced by the patient.
- Citations and Clinicians' Notes: Testicular Cancer. // Current Medical Literature: Urology;2003, Vol. 9 Issue 3, p86
Discusses two researches on testicular cancer previously published in the journal "Urology". "Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity," by A.A. Mosharafa et al; "Complications of primary nerve sparing retroperitoneal lymph node dissection...